Document and Entity Information
Document Type
Document Quarterly Report
Document Period End Date
Document Transition Report
Entity File Number
Entity Registrant Name
Entity Incorporation, State or Country Code
Entity Tax Identification Number
Entity Address, Address Line One
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Postal Zip Code
City Area Code
Local Phone Number
Title of 12(b) Security
Trading Symbol
Security Exchange Name
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Entity Shell Company
Entity Common Stock, Shares Outstanding
Entity Central Index Key
Current Fiscal Year End Date
Document Fiscal Year Focus
Document Fiscal Period Focus
Amendment Flag
INTERIM CONDENSED CONSOLIDATED BALANCE SHEETS
Statement [Table]
Statement [Table]
Statement [Line Items]
Statement
Assets [Abstract]
ASSETS
Assets, Current [Abstract]
Current Assets:
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents
Short-term Investments
Short-term deposit
Nontrade Receivables, Current
Other accounts receivable
Prepaid Expense and Other Assets, Current
Prepaid expenses and other current assets
Assets, Current
Total current assets
Assets, Noncurrent [Abstract]
Long-Term Assets:
Prepaid Expense and Other Assets, Noncurrent
Prepaid expenses and other long-term assets
Operating Lease, Right-of-Use Asset
Operating lease right of use asset
Operating lease right of use asset
Property, Plant and Equipment, Net
Property and Equipment, Net
Other Assets, Noncurrent
Total Long-Term Assets
Assets
Total assets
Liabilities and Equity [Abstract]
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
Liabilities, Current [Abstract]
Current Liabilities:
Accounts Payable, Current
Accounts payables
Accrued Liabilities, Current
Accrued expenses
Operating Lease, Liability, Current
Operating lease liability
The amount represents the other accounts payable current.
Other Accounts Payable Current
Other accounts payables
Liabilities, Current
Total current liabilities
Liabilities, Noncurrent [Abstract]
Long-Term Liabilities:
Operating Lease, Liability, Noncurrent
Operating lease liability
Liabilities, Noncurrent
Total long-term liabilities
Liabilities
Total liabilities
Stockholders' Equity Attributable to Parent [Abstract]
Stockholders' Equity:
Common Stock, Value, Issued
Stock capital: Common Stock of $0.00005 par value - Authorized: 100,000,000 shares June 30, 2023 and December 31, 2022 respectively; Issued and outstanding: 40,926,745 and 36,694,078 shares at June 30, 2023 and December 31, 2022 respectively.
Additional Paid in Capital, Common Stock
Additional paid-in-capital
Treasury Stock, Common, Value
Treasury stocks
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Stockholders' Equity Attributable to Parent
Balance
Balance
Total stockholders' equity (deficit)
Liabilities and Equity
Total liabilities and stockholders' equity (deficit)
Common Stock, Par or Stated Value Per Share
Common Stock, par value (in dollars per share)
Common Stock, Shares Authorized
Common Stock, shares authorized
Common Stock, Shares, Issued
Common Stock, shares issued
Common Stock, Shares, Outstanding
Common Stock, shares outstanding
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
Operating Expenses [Abstract]
Operating expenses:
Research and Development Expense
Research and development, net
General and Administrative Expense
General and administrative
Operating Income (Loss)
Operating loss
Represents the amount of financial expenses (income), net during the period.
Financial Expenses Income Net
Financial expenses (income), net
Net Income (Loss) Attributable to Parent
Net loss
Net loss
Earnings Per Share, Basic
Basic net loss per share from continuing operations
Earnings Per Share, Diluted
Diluted net loss per share from continuing operations
Weighted Average Number of Shares Outstanding, Basic
Weighted average number of shares outstanding used in computing basic net loss per share
Weighted Average Number of Shares Outstanding, Diluted
Weighted average number of shares outstanding used in computing diluted net loss per share
STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY
Equity Components [Axis]
Equity Component [Domain]
Common Stock [Member]
Common stock
Additional Paid-in Capital [Member]
Additional paid-in capital
Treasury Stocks [Member]
Treasury stocks
Accumulated Deficit [Member]
Accumulated deficit
Shares, Outstanding
Balance (in shares)
Balance (in shares)
Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees
Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures
Stock-based compensation related to stock and options granted to directors and employees (in shares)
Represents the information pertaining to issuance under at the market.
Issuance Of Shares At The Market
Issuance of shares in at-the-market (ATM) offering
Represents the information pertaining to issuance under at the market.
Issuance Of Share Value
Issuance of shares in at-the-market (ATM) offering (in shares)
INTERIM CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation
Depreciation
Stock or Unit Option Plan Expense
Stock-based compensation related to options granted to employees and directors
Increase (Decrease) in Operating Lease Liability
Change in operating lease liability
It represents the increase (decrease) during the reporting period in accounts receivable and prepaid expenses.
Increase Decrease In Accounts Receivable and Prepaid Expenses
Decrease in other accounts receivable and prepaid expenses
Increase (Decrease) in Accounts Payable, Trade
Increase (decrease) in trade payables
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Decrease in other accounts payable and accrued expenses
Net Cash Provided by (Used in) Operating Activities
Total net cash used in operating activities
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment
Purchase of property and equipment
Payments for (Proceeds from) Investments
Changes in short-term deposit
Net Cash Provided by (Used in) Investing Activities
Total net cash used in investing activities
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities:
Amount of cash inflow from at the market.
Proceeds From At The Market
Proceeds from issuance of shares in at-the-market (ATM) offering
Net Cash Provided by (Used in) Financing Activities
Total net cash provided by financing activities
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Decrease in cash and cash equivalents
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
Cash and cash equivalents at end of the period
Cash and cash equivalents at the beginning of the period
GENERAL
Business Description and Basis of Presentation [Text Block]
GENERAL
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation and Significant Accounting Policies [Text Block]
BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
RESEARCH AND LICENSE AGREEMENT
The entire disclosure on research and license agreement entered by the entity.
Research and License Agreement [Text Block]
RESEARCH AND LICENSE AGREEMENT
SHORT TERM DEPOSITS
The entire disclosure of the components short-term deposits.
Short Term Deposits Disclosure [Text Block]
SHORT TERM DEPOSITS
PREPAID EXPENSES
The entire disclosure for Prepaid Expenses.
Prepaid Expenses Disclosures [Text Block]
PREPAID EXPENSES
LEASES
Lessee, Operating Leases [Text Block]
LEASES
STOCK CAPITAL
Stockholders' Equity Note Disclosure [Text Block]
STOCK CAPITAL
SUBSEQUENT EVENTS
Subsequent Events [Text Block]
SUBSEQUENT EVENTS
Disclosure of accounting policy pertaining to unaudited interim financial statements.
Unaudited Interim Financial Statements Policy [Policy Text Block]
Unaudited Interim Financial Statements
Significant Accounting Policies [Text Block]
Significant Accounting Policies
New Accounting Pronouncements, Policy [Policy Text Block]
Recent Accounting Standards
Use of Estimates, Policy [Policy Text Block]
Use of estimates
Lease, Cost [Table Text Block]
Schedule of supplemental cash flow information related to operating leases
Lessee, Operating Lease, Liability, Maturity [Table Text Block]
Schedule of future lease payments under operating leases
Share-based Compensation, Stock Options, Activity [Table Text Block]
Summary of the Company's option activity
Schedule of Share-based Compensation, Restricted Stock and Restricted Stock Units Activity [Table Text Block]
Schedule of compensation expense for restricted stock is based on fair market value at the grant date
Tabular disclosure includes the number and weighted-average issue prices for warrants issued to services providers that were outstanding at the beginning and end of the year, and issued during the year.
Schedule Stock Awards Activity Related To Service Providers [Table Text Block]
Schedule of total stock-based compensation expense
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is covered by a valid claim or is covered by orphan drug status.
Percentage of Royalty Payment if Licensed Product Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product covered by valid claim or orphan drug status
Represents the percentage of all net sales royalty that the company will pay if the making, producing, manufacturing, using, marketing, selling, importing or exporting of such licensed product is not covered by a valid claim or is not covered by orphan drug status.
Percentage of Royalty Payment If Licensed Product Not Covered by Valid Claim or Orphan Drug Status
Percentage of royalty payment if licensed product not covered by valid claim or orphan drug status
This element represents the validity of the royalties' payments by the company not covered by a Valid Claim or Orphan Drug Status in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.
Validity of Royalty Payment Not Covered by Valid Claim or Orphan Drug Status
Validity of royalty payment not covered by valid claim or orphan drug status
Tabular disclosure of short term deposits.
Schedule of Short Term Deposits [Table]
Statistical Measurement [Axis]
Statistical Measurement [Domain]
Minimum [Member]
Minimum
Maximum [Member]
Maximum
Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.
Short Term Deposits [Line Items]
SHORT TERM DEPOSITS
Investment Interest Rate
Annual interest rate on bank deposits
Prepaid Expense
Prepaid expense
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
LEASES
Operating Lease, Liability
Operating lease liability
Total lease liability balance
Operating Lease, Weighted Average Remaining Lease Term
Operating lease, weighted average remaining lease term
Operating Lease, Weighted Average Discount Rate, Percent
Operating lease, weighted average discount rate percent
Operating Lease, Payments
Cash payments for operating leases
Lessee, Operating Lease, Liability, to be Paid, Year One
2023
Lessee, Operating Lease, Liability, to be Paid, Year Two
2024
Lessee, Operating Lease, Liability, to be Paid, Year Three
2025
Lessee, Operating Lease, Liability, to be Paid, Year Four
2026
Lessee, Operating Lease, Liability, to be Paid
Total future lease payments
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less imputed interest
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Sale of Stock [Axis]
Sale of Stock [Domain]
This member represents at market offering.
At Market Offering [Member]
At Market Offering
Option Indexed to Issuer's Equity, Type [Axis]
Option Indexed to Issuer's Equity, Type [Domain]
This member stands for Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014.
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014 [Member]
Global Share Option Plan 2014 And US Stock Option And Incentive Plan 2014
Award Type [Axis]
Equity Award [Domain]
Share-Based Payment Arrangement, Option [Member]
Employee Stock Option
Restricted Stock [Member]
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
STOCK CAPITAL
Class of Warrant or Right, Exercise price
Class of warrant exercise price
Stock Issued During Period, Value, New Issues
Aggregate offering amount
Stock Issued During Period, Shares, New Issues
Aggregate shares sold
Proceeds from Issuance of Common Stock
Gross proceeds
Stock Issued During Period, Shares, Issued for Services
Issuance of common stock
Common Stock, Capital Shares Reserved for Future Issuance
Future issuance of common stock
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount
Unrecognized compensation cost
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Weighted average period
Share-based Compensation
Compensation expense (income)
Total stock-based compensation expense
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number
Amount of options, Outstanding at end of period
Amount of options, Outstanding at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Amount of options, Granted
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Amount of options, Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number
Amount of options, Exercisable at end of period | shares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted average exercise price, Outstanding at end of period (in dollars per share)
Weighted average exercise price, Outstanding at beginning of period (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted average exercise price, Granted (in dollars per share)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average exercise Price, Forfeited (in dollars per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Weighted average exercise price, Exercisable at end of period (in dollars per share)
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Number of Shares of Restricted Stock, Nonvested at end of period
Number of Shares of Restricted Stock, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Nonvested at end of period
Weighted Average Grant Date Fair Value, Nonvested at beginning of period
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Forfeited
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms
Weighted Average Remaining Contractual Term (Years), Nonvested
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table]
Income Statement Location [Axis]
Income Statement Location [Domain]
Research and Development Expense [Member]
Research and development
General and Administrative Expense [Member]
General and administrative
Share-based Compensation Arrangement by Share-based Payment Award, Compensation Cost [Line Items]
STOCK CAPITAL
Subsequent Event [Table]
Subsequent Event Type [Axis]
Subsequent Event Type [Domain]
Subsequent Event [Member]
Subsequent Event
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Represents the information pertaining to securities purchase agreement.
Securities Purchase Agreement [Member]
Securities purchase agreement
Represents the information pertaining to public offering.
Public Offering [Member]
Public offering
Subsequent Event
SUBSEQUENT EVENTS
It represents the number of shares agreed to sell.
Number of Common Stock Agreed to Sell
Number of shares agreed to sell
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right
Shares issued upon exercise of warrants
Shares Issued, Price Per Share
Purchase price per share
Proceeds from Issuance or Sale of Equity
Gross proceeds
Warrants and Rights Outstanding, Term
Warrants term